http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200522974-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae84948901b77f34fd51c41264d8d19c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-078 |
| filingDate | 2005-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_697c457f052c9fce2ca49f32e8cd6e7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e50574816e4bc2ae536d3ed1d2c60c7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf825d66414f34bd8a4a19afb53c0089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85d15740e6dd937e6e3dff40bca5fb7e |
| publicationDate | 2005-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200522974-A |
| titleOfInvention | Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders |
| abstract | The invention relates to a novel use of known benzazepine, benzoxazepine, benzothiazepine-N-acetic acid and phosphono-substituted benzazepinone derivatives having neutral endopeptidase (NEP) and/or human soluble endopeptidase (Hsep) inhibitory activity. The compounds of the invention are useful for the preparation of pharmaceutical compositions for prophylaxis and treatment of neurodegenerative disorders. The compounds of the invention are known from the European patents EP 0 733 642 10 and EP 0 916 679, and can be described by the general formulae (1): , wherein the symbols have the meanings as given above in the description. |
| priorityDate | 2004-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.